pp 1–11 | Cite as

Post-malaria neurological syndrome: a rare neurological complication of malaria

  • Sanjay K. YadavaEmail author
  • Ashley Laleker
  • Tasaduq Fazili



Post-malaria neurological syndrome (PMNS) is a rare self-limiting neurological complication that can occur after recovery from malaria, usually severe falciparum malaria. It is characterized by a myriad of neuropsychiatric manifestations including mild neurological deficit to severe encephalopathy. PMNS was first described in 1996 and since then there have been 48 cases reported in the English literature. We report another case of PMNS in a 24-year-old healthy male and present a review of the disease entity.


We searched PMNS-related journal articles and case reports in the English literature, using PubMed and Google search engines. A total of forty-nine cases meeting the diagnostic criteria of PMNS were selected in this review.


PMNS is a rare complication of severe malaria that might be underreported. It can develop up to 2 months after clearance of parasitemia. Clinical features can be variable. Most cases are self-limited, but more severe cases may benefit from steroid therapy.


Post-malaria neurological syndrome (PMNS) Falciparum malaria 


Compliance with ethical standards

Conflict of interest

The authors declare that they have no competing interests.


  1. 1.
    Nguyen TH, Day NP, Ly VC, et al. Post-malaria neurological syndrome. Lancet. 1996;348:917–21.CrossRefGoogle Scholar
  2. 2.
    O’Brien MD, Jagathesan T. Lesson of the month 1: post-malaria neurological syndromes. Clin Med. 2016;16:292–3.CrossRefGoogle Scholar
  3. 3.
    Mohsen AH, McKendrick MW, Schmid ML, et al. Postmalaria neurological syndrome: a case of acute disseminated encephalomyelitis? J Neurol Neurosurg Psychiatry. 2000;68:388–9.CrossRefGoogle Scholar
  4. 4.
    Schnorf H, Diserens K, Schnyder H, et al. Corticosteroid responsive postmalaria encephalopathy characterized by motor aphasia, myoclonus, and postural tremor. Arch Neurol. 1998;55:417–20.CrossRefGoogle Scholar
  5. 5.
    Lawn SD, Flanagan LK, Wright SG, et al. Postmalaria neurological syndrome: two cases from the Gambia. Clin Infect Dis. 2003;36:e29–31.CrossRefGoogle Scholar
  6. 6.
    Falchook GS, Malone CM, Upton S, Shandera WX. Post malaria neurological syndrome after treatment of Plasmodium falciparum malaria in the United States. Clin Infect Dis. 2003;37:e22-24.CrossRefGoogle Scholar
  7. 7.
    Hsieh CF, Shih PY, Lin RT. Postmalaria neurological syndrome: a case report. Kaohsiung J Med Sci. 2006;22:630–5.CrossRefGoogle Scholar
  8. 8.
    Palmieri F, Petrosillo N, Paglia MG, et al. Genetic confirmation of quinine-resistant plasmodium falciparum malaria followed by postmalaria neurological syndrome in a traveler from Mozambique. J Clin Microbiol. 2004;42:5424–6.CrossRefGoogle Scholar
  9. 9.
    Zambito Marsala S, Ferracci F, Cecotti L, Gentile M, Conte F, Candeago RM, Marchini C. Post malaria neurological syndrome: clinical and laboratory findings in one patient. Neurol Sci. 2006;27:442–4.CrossRefGoogle Scholar
  10. 10.
    Silva-Pinto A, Costa A, Alves J, Silva NN, Abreu C, Santos L, Sarmento A. Post-malaria neurological syndrome: report of 3 cases from a Portuguese malaria reference centre. 2017. Accessed 24 Apr 2017
  11. 11.
    van der Wal G, Verhagen WI, Dofferhoff AS. Neurological complications following plasmodium falciparum infection. Neth J Med. 2005;63:180–3.Google Scholar
  12. 12.
    Mizuno Y, Kato Y, Kanagawa S, et al. A case of postmalaria neurological syndrome in Japan. J Infect Chemother. 2006;12:399–401.CrossRefGoogle Scholar
  13. 13.
    Prendki V, Elziere C, Durand R, et al. Post-malaria neurological syndrome—two cases in patients of African origin. Am J Trop Med Hyg. 2008;78:699–701.CrossRefGoogle Scholar
  14. 14.
    Markley JD, Edmond MB. Post-malaria neurological syndrome: a case report and review of the literature. J Travel Med. 2009;16:424–30.CrossRefGoogle Scholar
  15. 15.
    Matias G, Canas N, Antunes I, Vale J. Post-malaria neurologic syndrome. Acta Med Port. 2008;21:387.Google Scholar
  16. 16.
    Odawara T, Matsumura T, Maeda T, Washizaki K, Iwamoto A, Fujii T. A case of post-malarial neurological syndrome (PMNS) after treatment of falciparum malaria with artesunate and mefloquine. Trop Med Health. 2009;37:125–8.CrossRefGoogle Scholar
  17. 17.
    Rakotoarivelo RA, Razafimahefa SH, Andrianasolo R, Fandresena FH, Razanamparany MM, Randria MJ, Rapelanoro Rabenja F. Post-malaria neurological syndrome complicating a Plasmodium falciparum malaria in Madagascar. Bull Soc Pathol Exot. 2012;105:199–201.CrossRefGoogle Scholar
  18. 18.
    Pace AA, Edwards S, Weatherby S. A new clinical variant of the post-malaria neurological syndrome. J Neurol Sci. 2013;334:183–5.CrossRefGoogle Scholar
  19. 19.
    Mittal S, Misri ZK, Rakshith KC, Mittal S. Post malarial neurological syndrome: an uncommon cause. J Neuroinfect Dis. 2015;S1:004.Google Scholar
  20. 20.
    Costa A, Silva-Pinto A, Alves J, et al. Postmalaria neurologic syndrome associated with neurexin-3α antibodies. Neurol Neuroimmunol Neuroinflamm. 2017;4:e39.CrossRefGoogle Scholar
  21. 21.
    Chiabi A, Bogne JB, Nguefack S, Mah E, Siyou H, Djimafo A, Defo A, Angwafo F. Post malaria neurological syndrome in a Cameroonian child after a Plasmodium falciparum malaria infection. J Public Health Emerg. 2017;1:6.CrossRefGoogle Scholar
  22. 22.
    Siriez JY, Prendki V, Dauger S, Michel JF, Blondé R, Faye A, Houzé S, Mercier JC. Post-malaria neurologic syndrome: a rare pediatric case report. Pediatr Infect Dis J. 2017;36:1217–9.CrossRefGoogle Scholar
  23. 23.
    Almuntaser S, Costello A, Lynch B, et al. G320(P) post-malaria neurological syndrome: the first Irish paediatric case. Arch Dis Child. 2018;103:A130.CrossRefGoogle Scholar
  24. 24.
    Senanayake N, de Silva HJ. Delayed cerebellar ataxia complicating falciparum malaria: a clinical study of 74 patients. J Neurol. 1994;241:456–9.CrossRefGoogle Scholar
  25. 25.
    Donati D, Zhang LP, Chêne A, Chen Q, Flick K, Nyström M, Wahlgren M, Bejarano MT. Identification of a polyclonal B-cell activator in Plasmodium falciparum. Infect Immun. 2004;72:5412–8. Erratum in: Infect Immun. 2005;73:7790.Google Scholar
  26. 26.
    Adu D, Williams DG, Quakyi IA, Voller A, Anim-Addo Y, Bruce-Tagoe AA, Johnson GD, Holborow EJ. Anti-ssDNA and antinuclear antibodies in human malaria. Clin Exp Immunol. 1982;49:310–6.Google Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  • Sanjay K. Yadava
    • 1
    Email author
  • Ashley Laleker
    • 1
  • Tasaduq Fazili
    • 1
  1. 1.Department of Medicine, Division of Infectious DiseaseSUNY Upstate Medical CenterSyracuseUSA

Personalised recommendations